James Gulley of the National Cancer Institute talks to us about his work developing cancer immunotherapies, his insights into the impact of this modality in prostate cancer and his hopes for the future of the field.
In this interview, Mario Suva (Massachusetts General Hospital) speaks to us about his work looking into the biology of brain tumors and recent work his lab has carried out attempting to characterize oligodendrogliomas at the single-cell level.
Dr Hafez Halawani talks to Oncology Central regarding the predictive and prognostic potential of tumor location in metastatic colorectal cancer – a debate that was perpetuated with the presentation of the Venook et al study at the 2016 ASCO meeting.
Meenhard Herlyn, Caspar Wistar Professor for Melanoma Research and Director of the Melanoma Research Center at The Wistar Institute (PA, USA) and Founding President of the Society for Melanoma Research speaks to Melanoma Management about his 40 years in melanoma research.
WCRF have recently released a new CUP report discussing the link between various lifestyle factors and the development of esophageal cancer. We spoke with Susannah Brown (Scientific Programme Manager – Research Evidence at WCRF) about the work behind this report and what the main findings were.
In this interview, Consultant Clinical Oncologist Richard Simcock discusses single-dose intraoperative radiotherapy (SD-IORT) for early stage breast cancer – a…
In this interview, Danil V Makarov of NYU Langone Medical Center speaks about his work investigating regional variations in cancer imaging use in the USA and discusses the Choosing Wisely initiative.